细胞
医学
免疫印迹
免疫组织化学
病理
肺动脉高压
内皮干细胞
慢性血栓栓塞性肺高压
基因表达
分子生物学
基因
生物
内科学
遗传学
生物化学
体外
作者
Yi Zhao,Siyi Wanggou,Meng Ding,X. Dong,George W. Zhao,Yi Diao,Yan Li Shaoqing Li Wugang Hou Hailong Dong Libo Yao,Licun Wu,John Granton,Marc de Perrot
标识
DOI:10.1016/j.healun.2020.01.1181
摘要
Purpose
Chronic thromboembolic pulmonary hypertension (CTEPH), is a progressive condition characterized by persistent elevation in pulmonary artery pressure due to thromboembolic occlusion of the pulmonary arteries. Little is known about the cells that make up the cast of pulmonary endarterectomy (PEA) and its immune microenvironment. Here we report a map of the cellular landscape of the human PEA specimen using single-cell RNA sequencing. Methods
Five human PEA specimen from the proximal pulmonary arteries were collected from CTEPH patients who underwent PEA surgery. The protocol was approved (University Health Network, REB# 18-5892). 10x sample processing and cDNA library preparation was prepared using the 10x Genomics Single Cell Reagent Kit. Molecular analysis, Western blot, and immunohistochemistry were also performed. Results
The transcriptional profiles of 12598 cells obtained by fractionating fresh tissues from five CTEPH patients after PEA are presented in Figure 1. Using gene expression patterns and immunohistochemical examinations, we identified 18 discrete cell populations with distinct endothelial cell, smooth muscle cell, monocyte/macrophage, T cell, B cell, and NK-like cell characteristics. Transcription of endothelin-1 was observed in endothelial cells from every patient. The expression of endothelin-1 was confirmed by Western blot and immunohistochemistry in the PEA specimen from an additional 14 CTEPH patients undergoing surgery. Conclusion
Single cell RNA sequencing demonstrates a large population of inflammatory cells combined with endothelial cells and smooth muscle cell in the cast of PEA. Endothelin-1 expression by endothelial cells may contribute to the development of PH in patients with CTEPH.
科研通智能强力驱动
Strongly Powered by AbleSci AI